CCWM
BIIB icon

Cassaday & Co Wealth Management’s Biogen BIIB Stock Holding History

Cassaday & Co Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Buy
+218
New +$40.2K ﹤0.01% 655

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cassaday & Co Wealth Management's BIIB Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Biogen (BIIB) in Q1 2026: 218 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #655 among its holdings.

1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Cassaday & Co Wealth Management held 218 shares of Biogen worth $40K as of Q1 2026.
  • Biogen was a new Cassaday & Co Wealth Management position in Q1 2026.
  • Biogen made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #655 holding.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.